{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:36Z","timestamp":1791225996035,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.020","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T05:50:48Z","timestamp":1453355448000},"page":"1201-1207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Shinji","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ainai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.020_bib0165","series-title":"Fields virology","first-page":"1186","article-title":"Orthomyxoviruses","author":"Wright","year":"2013"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.020_bib0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.020_bib0175","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4049\/jimmunol.160.3.1219","article-title":"In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA","volume":"160","author":"Renegar","year":"1998","journal-title":"J Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2016.01.020_bib0180","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.1503885112","article-title":"Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus","volume":"112","author":"Suzuki","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.020_bib0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2012","journal-title":"Exp Rev Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2016.01.020_bib0190","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0264-410X(03)00078-1","article-title":"Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia","volume":"21","author":"Ito","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.020_bib0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmv.20173","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus","volume":"74","author":"Asahi-Ozaki","year":"2004","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.020_bib0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/14760584.6.2.193","article-title":"Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic","volume":"6","author":"Hasegawa","year":"2007","journal-title":"Exp Rev Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2016.01.020_bib0205","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/j.vaccine.2010.05.019","article-title":"Studies on the usefulness of intranasal inactivated influenza vaccines","volume":"28","author":"Tamura","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.020_bib0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.398","article-title":"New generation of mucosal adjuvants for the induction of protective immunity","volume":"13","author":"Yuki","year":"2003","journal-title":"Rev Med Virol"},{"issue":"6857","key":"10.1016\/j.vaccine.2016.01.020_bib0215","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappa]B by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.020_bib0220","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA Poly(I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.020_bib0225","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.micinf.2007.06.007","article-title":"Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge","volume":"9","author":"Ichinohe","year":"2007","journal-title":"Microb Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.020_bib0230","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/jmv.21824","article-title":"Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus","volume":"82","author":"Ichinohe","year":"2010","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.020_bib0235","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"Ainai","year":"2013","journal-title":"Hum Vaccine Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.020_bib0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat Mater"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.020_bib0245","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.020_bib0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/02648725.2013.801226","article-title":"Nanogel-based antigen-delivery system for nasal vaccines","volume":"29","author":"Yuki","year":"2013","journal-title":"Biotechnol Genetic Eng Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.020_bib0255","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2016.01.020_bib0260","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","volume":"8","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.01.020_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2014.05.011","article-title":"Combatting infectious diseases; nanotechnology as a platform for rational vaccine design","volume":"74","author":"van Riet","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.020_bib0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(90)90011-A","article-title":"Influenza vaccine: enhancement of immune response by application of carboxy-vinylpolymer","volume":"8","author":"Oka","year":"1990","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.020_bib0275","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.020_bib0280","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's Palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.020_bib0285","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1001789","article-title":"In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against Botulism in nonhuman primates","volume":"185","author":"Yuki","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.020_bib0290","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.020_bib0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2016.01.020_bib0300","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J Anat"},{"key":"10.1016\/j.vaccine.2016.01.020_bib0305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2307\/3430686","article-title":"Comparative pathology of the nasal mucosa in laboratory animals exposed to inhaled irritants","volume":"85","author":"Harkema","year":"1990","journal-title":"Environ Health Perspect"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.020_bib0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jam.1997.10.319","article-title":"A comparative analysis of primate nasal airways using magnetic resonance imaging and nasal casts","volume":"10","author":"Yeh","year":"1997","journal-title":"J Aerosol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.020_bib0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol Pathol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.020_bib0320","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:13:24Z","timestamp":1718316804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000554"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}